172 related articles for article (PubMed ID: 1585829)
1. Physicochemical action of potassium-magnesium citrate in nephrolithiasis.
Pak CY; Koenig K; Khan R; Haynes S; Padalino P
J Bone Miner Res; 1992 Mar; 7(3):281-5. PubMed ID: 1585829
[TBL] [Abstract][Full Text] [Related]
2. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
[TBL] [Abstract][Full Text] [Related]
3. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
Pak CY; Peterson R
Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
[TBL] [Abstract][Full Text] [Related]
5. Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate.
Odvina CV; Mason RP; Pak CY
Am J Ther; 2006; 13(2):101-8. PubMed ID: 16645424
[TBL] [Abstract][Full Text] [Related]
6. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
7. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
Sakhaee K; Poindexter JR; Griffith CS; Pak CY
J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
[TBL] [Abstract][Full Text] [Related]
8. Successful management of uric acid nephrolithiasis with potassium citrate.
Pak CY; Sakhaee K; Fuller C
Kidney Int; 1986 Sep; 30(3):422-8. PubMed ID: 3784284
[TBL] [Abstract][Full Text] [Related]
9. Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
Ruml LA; Gonzalez G; Taylor R; Wuermser LA; Pak CY
Am J Ther; 1999 Jan; 6(1):45-50. PubMed ID: 10423646
[TBL] [Abstract][Full Text] [Related]
10. Effects of potassium-magnesium citrate supplementation on cytosolic ATP citrate lyase and mitochondrial aconitase activity in leukocytes: a window on renal citrate metabolism.
Tosukhowong P; Tungsanga K; Phongudom S; Sriboonlue P
Int J Urol; 2005 Feb; 12(2):140-4. PubMed ID: 15733107
[TBL] [Abstract][Full Text] [Related]
11. [Citrate (CG-120) therapy in urolithiasis. 2. Effect on urinary and serum biochemistry ].
Ohkawa T; Ebisuno S; Morimoto S; Yasukawa S; Sonoda T; Koide T; Oka T; Aso Y; Higashihara E; Kitagawa R
Hinyokika Kiyo; 1988 May; 34(5):918-31. PubMed ID: 3051946
[TBL] [Abstract][Full Text] [Related]
12. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
13. Urinary response to oral potassium citrate therapy for urolithiasis in a private practice setting.
Nicar MJ; Hsu MC; Fetner C
Clin Ther; 1986; 8(2):219-25. PubMed ID: 3698069
[TBL] [Abstract][Full Text] [Related]
14. Citrate and renal calculi: new insights and future directions.
Pak CY
Am J Kidney Dis; 1991 Apr; 17(4):420-5. PubMed ID: 2008910
[TBL] [Abstract][Full Text] [Related]
15. Potassium-magnesium citrate versus potassium chloride in thiazide-induced hypokalemia.
Wuermser LA; Reilly C; Poindexter JR; Sakhaee K; Pak CY
Kidney Int; 2000 Feb; 57(2):607-12. PubMed ID: 10652038
[TBL] [Abstract][Full Text] [Related]
16. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
17. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.
Ettinger B; Pak CY; Citron JT; Thomas C; Adams-Huet B; Vangessel A
J Urol; 1997 Dec; 158(6):2069-73. PubMed ID: 9366314
[TBL] [Abstract][Full Text] [Related]
18. In vivo 31P-MRS assessment of muscle-pH, cytolsolic-[Mg2+] and phosphorylation potential after supplementing hypokaliuric renal stone patients with potassium and magnesium salts.
Mairiang E; Hanpanich P; Sriboonlue P
Magn Reson Imaging; 2004 Jun; 22(5):715-9. PubMed ID: 15172066
[TBL] [Abstract][Full Text] [Related]
19. Contrasting effects of various potassium salts on renal citrate excretion.
Sakhaee K; Alpern R; Jacobson HR; Pak CY
J Clin Endocrinol Metab; 1991 Feb; 72(2):396-400. PubMed ID: 1899422
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts.
Sakhaee K; Nicar M; Hill K; Pak CY
Kidney Int; 1983 Sep; 24(3):348-52. PubMed ID: 6645208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
